A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology

D Pastori, VM Cormaci, S Marucci, G Franchino… - International Journal of …, 2023 - mdpi.com
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …

Systemic lupus erythematosus: a review

CH Siegel, LR Sammaritano - Jama, 2024 - jamanetwork.com
Importance Systemic lupus erythematosus (SLE) is a chronic autoimmune disease
characterized by inflammation and immune-mediated injury to multiple organ systems …

The 2023 ACR/EULAR antiphospholipid syndrome classification criteria

M Barbhaiya, S Zuily, R Naden, A Hendry… - Arthritis & …, 2023 - Wiley Online Library
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …

Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report

SM Stevens, SC Woller, LB Kreuziger, H Bounameaux… - Chest, 2021 - Elsevier
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis

SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - Elsevier
These guidelines are dedicated to the memory of Dr Clive Kearon of McMaster University in
Hamilton, Ontario, Canada. Dr Kearon extensively reviewed the first and second versions of …

The unique characteristics of COVID-19 coagulopathy

T Iba, JH Levy, JM Connors, TE Warkentin, J Thachil… - Critical care, 2020 - Springer
Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the
characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen …

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

SX Gu, T Tyagi, K Jain, VW Gu, SH Lee… - Nature Reviews …, 2021 - nature.com
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course

J Muri, V Cecchinato, A Cavalli, AA Shanbhag… - Nature …, 2023 - nature.com
Infection with severe acute respiratory syndrome coronavirus 2 associates with diverse
symptoms, which can persist for months. While antiviral antibodies are protective, those …

[HTML][HTML] Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis …

KMJ Devreese, PG de Groot, B de Laat, D Erkan… - Journal of thrombosis …, 2020 - Elsevier
This guidance focuses on methodological aspects of lupus anticoagulant (LA) testing, as
well as interpretation of results for clinicians. The main changes in how to test for LA …

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

JS Knight, DW Branch, TL Ortel - Bmj, 2023 - bmj.com
Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …